| 5α-Androstane-3β,17β-diol | |
|---|---|
|
(3β,5α,17β)-Androstane-3,17-diol |
|
| Identifiers | |
| PubChem | 242332 |
| ChemSpider | 211834 |
| Jmol-3D images | Image 1 |
|
|
|
|
| Properties | |
| Molecular formula | C19H32O2 |
| Molar mass | 292.456 g/mol |
| Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) | |
| Infobox references | |
5α-Androstane-3β,17β-diol, also called 3β-androstanediol, and often shortened to 3β-diol, is an endogenous steroid hormone. It is a 5α-reduced and 17β-hydroxylated metabolite of dehydroepiandrosterone (DHEA) as well as a 3β-hydroxylated metabolite of dihydrotestosterone (DHT). Similarly to DHEA, 3β-diol is a high-affinity full agonist of the ERβ, and hence, an estrogen. In contrast, it does not bind to the androgen receptor.[1] As a result of activation of the ERβ, 3β-diol has antiproliferative effects against prostate cancer cells and proliferative effects on breast cancer cells.[2][3]
A determination of the circulating levels of 3β-diol in humans found concentrations of 239 ± 76 pg/ml and 82 ± 45 pg/ml of the compound in normal male and female serum.[4]
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)